GOF mutations of PCSK9 [1, 15, 72] lead to hypercholesterolemia while non-sense mutations [1] or LOF-mutations [15, 17, 34, 45] reduce the LDL-C concentration (Fig. 1). This evidence concerns the gene PCSK9 and Hypercholesterolemia.